NU-MED PLUS, INC.

NUMD ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Nov 2023 Sep 2023 Aug 2023 Jun 2023 May 2023 Mar 2023 Mar 2023 Dec 2022
Revenue
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $8.8K $6.6K $6.4K
Operating Income $-15.1K $-23.1K $-27.0K
Operating Margin
Interest Expense $1.3K $1.2K $1.2K
Pretax Income $-16.4K $-24.3K
Income Tax Expense
Net Income $-16.4K $-24.3K $-28.2K
Net Margin
EPS (Basic) $0.00 $0.00 $0.00
EPS (Diluted) $0.00 $0.00 $0.00
Shares Outstanding (Basic) 81.3M 81.3M 81.3M 81.3M 81.3M 81.3M 81.3M 81.3M
Shares Outstanding (Diluted) 81.3M 81.3M 81.3M 81.3M 81.3M 81.3M 81.3M 81.3M
Dividends Per Share
← Newer Page 3 of 13 Older →
Peter Lynch

Ten years of filings tell you more than one hot tip ever will.